Pedro Rocha
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 20
- Lung Cancer Research Studies 11
- Peptidase Inhibition and Analysis 7
- Cancer Immunotherapy and Biomarkers 6
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Edurne Arriola (21 shared papers)Álvaro Taus (16 shared papers)Max Hardy-Werbin (13 shared papers)Joan Albanell (8 shared papers)Sergi Clavé (11 shared papers)Marta Salido (9 shared papers)Lara Pijuán (7 shared papers)João Primo (1 shared paper)
- Journals
- Journal of Thoracic Oncology (5 papers)Journal of Clinical Oncology (5 papers)Clinical Lung Cancer (4 papers)Annals of Oncology (2 papers)OncoImmunology (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Pedro Rocha
34 papers receiving 476 citations
Peers
Comparison fields: 5 of 50
- Oncology 232
- Cancer Research 87
- Pulmonary and Respiratory Medicine 136
- Internal Medicine 10
- Cardiology and Cardiovascular Medicine 64
Countries citing papers authored by Pedro Rocha
This map shows the geographic impact of Pedro Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Rocha more than expected).
Fields of papers citing papers by Pedro Rocha
This network shows the impact of papers produced by Pedro Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Rocha. The network helps show where Pedro Rocha may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Rocha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. | 2010 | 76 |
| 2 | 2017 | 70 | |
| 3 | 2019 | 68 | |
| 4 | 2018 | 45 | |
| 5 | 2019 | 34 | |
| 6 | 2017 | 29 | |
| 7 | 2014 | 28 | |
| 8 | 2018 | 24 | |
| 9 | 2014 | 17 | |
| 10 | 2019 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2025 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2025 | 5 | |
| 15 | 2018 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2025 | 3 |
About Pedro Rocha
Pedro Rocha is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Surgery, having authored 37 papers that have together received 478 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (11 papers), Lung Cancer Treatments and Mutations (9 papers), Peptidase Inhibition and Analysis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Genomics and Diagnostics (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (232 citations), Cancer Research (87 citations), Pulmonary and Respiratory Medicine (136 citations), Internal Medicine (10 citations) and Cardiology and Cardiovascular Medicine (64 citations). Pedro Rocha has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Edurne Arriola, Álvaro Taus, Max Hardy-Werbin, Joan Albanell, Sergi Clavé, Marta Salido, Lara Pijuán, João Primo, João de Sousa and Pedro Adragão. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Clinical Lung Cancer, Annals of Oncology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.